We are live on ! Find out more
ORGS

Orgenesis Inc. Common Stock
ORGS

Delisted

ORGS was delisted on the 18th of October, 2024.

Back to rankings

18 hedge funds and large institutions have $3.57M invested in Orgenesis Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more capital invested

Capital invested by funds: $2.01M → $3.57M (+$1.56M)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

13% more funds holding

Funds holding: 16 → 18 (+2)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VCM
Venator Capital Management
Ontario, Canada
+$928K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$133K
3
Squarepoint
Squarepoint
New York
+$96.4K
4
TSS
Two Sigma Securities
New York
+$64K
5
TRCT
Tower Research Capital (TRC)
New York
+$3.74K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$23K
2
BlackRock
BlackRock
New York
-$9.23K
3
Citigroup
Citigroup
New York
-$2K
4
CPA
Cowen Prime Advisors
New York
-$2K
5
UBS Group
UBS Group
Switzerland
-$998
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.63M +$133K +2,669 +10%
VCM
2
Venator Capital Management
Ontario, Canada
$991K +$928K +18,588 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$242K – – –
CCMU
4
Cheyne Capital Management (UK)
United Kingdom
$208K – – –
BlackRock
5
BlackRock
New York
$144K -$9.23K -185 -6%
Squarepoint
6
Squarepoint
New York
$103K +$96.4K +1,932 New
Northern Trust
7
Northern Trust
Illinois
$81K +$649 +13 +0.9%
TSS
8
Two Sigma Securities
New York
$68K +$64K +1,283 New
GHA
9
GW Henssler & Associates
Georgia
$59K – – –
TFGT
10
TS Financial Group (TSFG)
Illinois
$13K +$12.5K +250 New
Wells Fargo
11
Wells Fargo
California
$11K – – –
UBS Group
12
UBS Group
Switzerland
$6K -$998 -20 -16%
AG
13
Advisor Group
Arizona
$6K – – –
WEC
14
Winslow Evans & Crocker
Massachusetts
$6K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$4K +$3.74K +75 New
Bank of America
16
Bank of America
North Carolina
$1K – – –
SFG
17
SevenBridge Financial Group
Pennsylvania
$1K – – –
Barclays
18
Barclays
United Kingdom
– -$23K -500 Closed
Citigroup
19
Citigroup
New York
– -$2K -50 Closed
CPA
20
Cowen Prime Advisors
New York
– -$2K -50 Closed

ORGS Hedge Fund Activity: Q1 2019 in Review

18 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q1 2019, worth a combined $3.57M — up 78% from $2.01M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ORGS positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Venator Capital Management, opening a new position worth an estimated $928K. The largest seller was Barclays, exiting entirely with an estimated $23K sold.

  • 18 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q1 2019, up from 16 in Q4 2018.
  • Funds reported $3.57M of Orgenesis Inc. Common Stock stock for Q1 2019, up 78% quarter-over-quarter.
  • 5 funds opened new Orgenesis Inc. Common Stock positions in Q1 2019 and 3 closed out, a net change of +2 holders.
  • The largest Orgenesis Inc. Common Stock buyer in Q1 2019 was Venator Capital Management, an estimated $928K added.
  • The largest Orgenesis Inc. Common Stock seller in Q1 2019 was Barclays, an estimated $23K sold.

Based on aggregated 13F filings for Q1 2019.